Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
Alterations in glycosylation in tumours facilitate tumour progression. Here, the authors show that pancreatic ductal adenocarcinomas present increased sialylation, which stimulates the polarisation of monocytes via Siglec receptors, resulting in the generation of immune suppressive tumour associated...
Guardado en:
Autores principales: | Ernesto Rodriguez, Kelly Boelaars, Kari Brown, R. J. Eveline Li, Laura Kruijssen, Sven C. M. Bruijns, Thomas van Ee, Sjoerd T. T. Schetters, Matheus H. W. Crommentuijn, Joost C. van der Horst, Nicole C. T. van Grieken, Sandra J. van Vliet, Geert Kazemier, Elisa Giovannetti, Juan J. Garcia-Vallejo, Yvette van Kooyk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/64cd1d7410f74f27b60dd9aca97082ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Siglecs as Therapeutic Targets in Cancer
por: Jackwee Lim, et al.
Publicado: (2021) -
Identification of Siglec-1 null individuals infected with HIV-1
por: Javier Martinez-Picado, et al.
Publicado: (2016) -
Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo.
por: Yung-Chi Chang, et al.
Publicado: (2014) -
Siglec-15 promotes progression of clear renal cell carcinoma
por: Wen-Bo Yang, et al.
Publicado: (2021) -
Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Hyeree Choi, et al.
Publicado: (2021)